Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alkermes plc | 12 | 2 | 3 | 1 | €22.20 | €34.08 | 53.517% |
| Medpace Holdings Inc | 6 | 0 | 0 | 0 | €351.60 | €399.91 | 13.739% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | €10.88 | €22.78 | 109.428% |
| Ensign Group Inc. | 7 | 0 | 0 | 0 | €110.00 | €116.00 | 5.455% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €66.00 | €86.72 | 31.389% |
| United Therapeutics | 15 | 0 | 0 | 0 | €222.50 | €289.92 | 30.301% |
| Taro Pharmaceutical Industries Ltd | 6 | 0 | 0 | 0 | €39.40 | - | - |
| Chemed Corp. | 4 | 0 | 0 | 0 | €560.00 | €588.14 | 5.025% |
| Select Medical Holdings | 3 | 0 | 1 | 0 | €24.60 | €36.41 | 47.994% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €78.00 | €97.90 | 25.515% |
| Integer Hldg | 1 | 0 | 0 | 0 | €109.00 | - | - |
| Amedisys Inc. | 13 | 0 | 3 | 0 | €83.50 | €92.26 | 10.491% |
| Icon plc | 15 | 0 | 3 | 0 | €270.90 | €318.32 | 17.505% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €90.50 | €124.85 | 37.953% |
| LivaNova plc | 6 | 0 | 2 | 0 | €48.00 | €64.66 | 34.706% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €19.80 | €31.74 | 60.298% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €58.50 | €75.80 | 29.573% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €74.00 | €79.00 | 6.757% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €213.90 | €247.61 | 15.759% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.44 | €26.01 | 21.299% |
| Neurocrine Bioscience | 21 | 0 | 3 | 0 | €124.50 | €137.10 | 10.120% |
| Tenet Healthcare | 23 | 0 | 3 | 0 | €86.00 | €95.79 | 11.389% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.41 | €55.00 | 4.942% |
| Bruker Corp. | 7 | 2 | 0 | 1 | €73.80 | €84.02 | 13.854% |